Search Results - "EYSTER, M. Elaine"

Multiyear Factor VIII Expression after AAV Gene Transfer for Hemophilia A by George, Lindsey A, Monahan, Paul E, Eyster, M. Elaine, Sullivan, Spencer K, Ragni, Margaret V, Croteau, Stacy E, Rasko, John E.J, Recht, Michael, Samelson-Jones, Benjamin J, MacDougall, Amy, Jaworski, Kristen, Noble, Robert, Curran, Marla, Kuranda, Klaudia, Mingozzi, Federico, Chang, Tiffany, Reape, Kathleen Z, Anguela, Xavier M, High, Katherine A

“…At a median follow-up of 3.5 years after gene therapy with a factor VIII–containing adeno-associated virus, 16 of 18 men with hemophilia A had enough factor…”
Get full text

A novel type 2N VWF gene mutation: a case report by Evans, Matthew S, Eyster, M Elaine

“…Men and boys who present with bleeding associated with low factor VIII levels and normal von Willebrand studies are assumed to have hemophilia A until proven…”
Get full text

Prospective, multicenter study of postoperative deep-vein thrombosis in patients with haemophilia undergoing major orthopaedic surgery by Buckner, Tyler W, Leavitt, Andrew D, Ragni, Margaret, Kempton, Christine L, Eyster, M Elaine, Cuker, Adam, Lentz, Steven R, Ducore, Jonathan, Leissinger, Cindy, Wang, Mike, Key, Nigel S

“…Perioperative clotting factor replacement is administered to reverse the inherent haemostatic defect in persons with haemophilia (PWH), potentially increasing…”
Get more information

A cross-sectional analysis of cardiovascular disease in the hemophilia population by Sood, Suman L., Cheng, Dunlei, Ragni, Margaret, Kessler, Craig M., Quon, Doris, Shapiro, Amy D., Key, Nigel S., Manco-Johnson, Marilyn J., Cuker, Adam, Kempton, Christine, Wang, Tzu-Fei, Eyster, M. Elaine, Kuriakose, Philip, von Drygalski, Annette, Gill, Joan Cox, Wheeler, Allison, Kouides, Peter, Escobar, Miguel A., Leissinger, Cindy, Galdzicka, Sarah, Corson, Marshall, Watson, Crystal, Konkle, Barbara A.

“…Men with hemophilia were initially thought to be protected from cardiovascular disease (CVD), but it is now clear that atherothrombotic events occur. The…”
Get full text

Diagnosing dehydrated hereditary stomatocytosis due to a KCNN4 Gardos channel mutation: understanding challenges through study of a multi‐generational family by Waldstein, Sasha, Arnold‐Croop, Sarah, Carrel, Laura, Eyster, M. Elaine

“…The majority of described DHSt cases result from gain-of-function mutations in the mechanosensitive cation channel gene PIEZO1, leading to an inappropriate…”
Get full text

Physician perceptions and use of reduced‐dose direct oral anticoagulants for extended phase venous thromboembolism treatment by Groat, Danielle, Martin, Karlyn A., Rosovsky, Rachel P., Sanfilippo, Kristen M., Gaddh, Manila, Kreuziger, Lisa Baumann, Eyster, M. Elaine, Woller, Scott C.

“…The direct oral anticoagulants (DOACs), apixaban and rivaroxaban, have been studied for extended‐phase treatment of venous thromboembolism (VTE). Yet, scant…”
Get full text

Anemia and the Need for Intravenous Iron Infusion after Roux-en-Y Gastric Bypass by Kotkiewicz, Adam, Donaldson, Keri, Dye, Charles, Rogers, Ann M., Mauger, David, Kong, Lan, Eyster, M. Elaine

“…The frequency of anemia, iron deficiency, and the long-term need for IV iron following Roux-en-y gastric bypass (RYGB) surgery has not been well characterized…”
Get full text

End-stage liver disease in persons with hemophilia and transfusion-associated infections by Goedert, James J., Eyster, M. Elaine, Lederman, Michael M., Mandalaki, Titica, de Moerloose, Philippe, White, Gilbert C., Angiolillo, Anne L., Luban, Naomi L.C., Sherman, Kenneth E., Manco-Johnson, Marilyn, Preiss, Liliana, Leissinger, Cindy, Kessler, Craig M., Cohen, Alan R., DiMichele, Donna, Hilgartner, Margaret W., Aledort, Louis M., Kroner, Barbara L., Rosenberg, Philip S., Hatzakis, Angelos

“…Many persons with hemophilia were infected with hepatitis C and B viruses (HCV, HBV) and HIV, but the consequences of these transfusion-acquired infections are…”
Get full text

HCV kinetics, quasispecies, and clearance in treated HCV‐infected and HCV/HIV‐1‐coinfected patients with hemophilia by Shire, Norah J., Horn, Paul S., Rouster, Susan D., Stanford, Sandra, Eyster, M. Elaine, Sherman, Kenneth E.

“…Hepatitis C virus (HCV) treatment response rates remain low in HCV/HIV‐1‐coinfected individuals compared with those with HCV alone. Persons with inherited…”
Get full text

DOAC compared with warfarin for VTE in low weight patients: A retrospective cohort study conducted through the VENUS network by Martin, Karlyn A., Lancki, Nicola, Kreuziger, Lisa Baumann, Li, Celina, Eyster, M. Elaine, Sanfilippo, Kristen, Woller, Scott C., Rosovsky, Rachel P.

“…•Limited data exist for use of DOACs for treatment of VTE in underweight patients.•We performed a multicenter retrospective study of DOACs vs warfarin in this…”
Get full text

Postoperative bleeding complications in patients with hemophilia undergoing major orthopedic surgery: A prospective multicenter observational study by Kleiboer, Brendan, Layer, Marcus A., Cafuir, Lorraine A., Cuker, Adam, Escobar, Miguel, Eyster, M. Elaine, Kraut, Eric, Leavitt, Andrew D., Lentz, Steven R., Quon, Doris, Ragni, Margaret V., Thornhill, Dianne, Wang, Michael, Key, Nigel S., Buckner, Tyler W.

“…Background Persons with hemophilia (PWH) are at risk for chronic hemophilic arthropathy (HA). Joint replacement surgery may be used to relieve intractable pain…”
Get full text

DOAC compared with warfarin for VTE in patients with obesity: a retrospective cohort study conducted through the VENUS network by Martin, Karlyn A, Lancki, Nicola, Li, Celina, Eyster, M. Elaine, Sanfilippo, Kristen, Woller, Isabela A., Woller, Scott C., Kreuziger, Lisa Baumann, Rosovsky, Rachel P.

“…The effectiveness and safety of direct oral anticoagulants (DOAC) compared with warfarin remains uncertain in obese patients. We assessed the comparative…”
Get full text

Long term survival in persons with hemophilia and chronic hepatitis C: 40 year outcomes of a large single center cohort by Eyster, M. Elaine, Kong, Lan, Li, Menghan, Schreibman, Ian R.

“…We studied the course of chronic HCV infections in a cohort of 222 persons with hemophilia (PWH) and von Willebrand disease followed at our center since 1973…”
Get full text

Prothrombotic variants as modifiers of clinical phenotype in four related individuals with haemophilia A by Carrel, Laura, Arnold‐Croop, Sarah, Achtermann, Ty, Chen, Fang, Cheng, Yuhuan, Liu, Dajiang, Eyster, M. Elaine

Get full text

Correction to: DOAC compared with warfarin for VTE in patients with obesity: a retrospective cohort study conducted through the VENUS network by Martin, Karlyn A, Lancki, Nicola, Li, Celina, Eyster, M. Elaine, Sanfilippo, Kristen, Woller, Isabela A., Woller, Scott C., Kreuziger, Lisa Baumann, Rosovsky, Rachel P.

Get full text

Investigation of discordant phenotype in mild Hemophilia A using whole exome sequencing by Cygan, Peter H., Arnold-Croop, Sarah E., Weidman, Elizabeth A., Chen, Fang, Liu, Dajiang J., Eyster, M. Elaine, Carrel, Laura

Get full text

Total knee replacement with and without emicizumab: a unique comparison of perioperative management by Evans, Matthew S., Davis, Charles, Eyster, M. Elaine

“…•Prophylaxis with emicizumab was used in a patient with severe hemophilia with an inhibitor who underwent knee surgery.•Use of emicizumab during surgery led to…”
Get full text

Prevalence and Changes in Hepatitis C Virus Genotypes among Multitransfused Persons with Hemophilia by Eyster, M. Elaine, Sherman, Kenneth E., Goedert, James J., Katsoulidou, Antigoni, Hatzakis, Angelos

“…The purpose of this study was to determine hepatitis C virus (HCV) genotypes and their relationship to HCV RNA levels over time in a cohort of multitransfused…”
Get full text

Correlates of spontaneous clearance of hepatitis C virus among people with hemophilia by Zhang, Mingdong, Rosenberg, Philip S., Brown, Deborah L., Preiss, Liliana, Konkle, Barbara A., Eyster, M. Elaine, Goedert, James J.

“…People with hemophilia were formerly at very high risk of infection with hepatitis C virus (HCV). Approximately 20% of HCV-infected patients spontaneously…”
Get full text

Evaluation of the efficacy and safety of etoricoxib in the treatment of hemophilic arthropathy by Tsoukas, Christos, Eyster, M. Elaine, Shingo, Sumiko, Mukhopadhyay, Saurabh, Giallella, Karen M., Curtis, Sean P., Reicin, Alise S., Melian, Agustin

“…This 2-part, double-blind, placebo-controlled study was conducted to determine the safety and efficacy of etoricoxib, a COX-2 selective inhibitor, for the…”
Get full text